Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the closing of its previously announced ...

Meeting young people receiving care at an oncology-hematology clinic in Poland, Pope Francis told them they are witnesses of ...

Novartis faces short-term challenges with patent expirations but shows long-term growth potential, making the stock a buy ...

Oncologists are praising the surgeon general's decision to add cancer-risk warning labels to alcohol.

The Piedmont Triad Regenerative Medicine Engine (PTRME), funded by the National Science Foundation (NSF), has awarded six regional companies $2.5 million in grants as part of its inaugural Ecosystem ...

IGM Biosciences has halted all oncology programs and faces a significant pipeline upheaval. Read why I maintain my Sell ...

Mentor, mother, activist, advocate, sister, survivor, researcher and Fred Hutch friend, Bridgette Hempstead died last month ...

The Head and Neck Radiation Oncology Group (GORTEC) announced significant improvement in disease-free survival for locally ...

A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor ...

Shares of NeoGenomics tumbled after the oncology testing-services company said its chief executive, Chris Smith, will retire April 1. The stock fell 20%, to $14.91, in afternoon trading Friday. Shares ...

Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.

Exelixis, Inc. EXEL announced that the FDA has notified it about an update to its supplemental new drug application (sNDA) ...